# Genetic Determinants of Radiosensitivity: Evidence of Radioresistance-Associated SNP Enrichment in Occupational Workers Chronically Exposed to Low-Dose Radiation

**Authors:** Dauren Botbayev, Kamalidin Sharipov, Ayaz Belkozhayev, Bakhytzhan Alzhanuly, Ulbossyn Yerkinbek, Daulet Sharipov, Alexandr Gulyayev, Sayagul Kairgeldina, Kanat Tekebayev, Gulnur Zhunussova, Madina Baurzhan

PMC · DOI: 10.3390/genes17020191 · 2026-02-03

## TL;DR

This study finds that workers exposed to low-dose radiation show genetic variants linked to increased radioresistance, particularly in TP53 and CDKN1A genes.

## Contribution

The study identifies specific SNPs associated with radioresistance in occupational workers exposed to chronic low-dose radiation.

## Key findings

- Four SNPs in TP53 and CDKN1A were significantly enriched in radiation-exposed workers.
- The strongest genetic deviations were observed in Russian workers from Stepnogorsk.
- These SNPs are linked to improved DNA repair and cell-cycle regulation.

## Abstract

Background: Interindividual radiosensitivity is largely driven by genetic regulation of DNA damage recognition, repair, and cell-cycle control. TP53 and CDKN1A (p21) are key genomic markers associated with differential responses to ionizing radiation. Methods: This study investigated eight functional SNP markers across several key genes involved in DNA damage responses and cellular stress regulation, including TP53, CDKN1A/p21, APC, VEGF, XPD, and RAD51, in occupational groups exposed to chronic low-dose ionizing radiation at the Stepnogorsk Mining Chemical Combine and the Balkashinskoye uranium deposit. Genotyping was performed using PCR-based assays followed by restriction fragment length polymorphism (RFLP) analysis. Allele and genotype frequencies were compared between radiation-exposed workers and matched controls within Kazakh and Russian ethnic subgroups. Statistical differences were assessed using χ2 tests, and associations with radioresistance were interpreted based on established functional characteristics of each polymorphism. Results: Four SNPs showed significant allele and genotype frequency shifts in radiation-exposed populations. The TP53 intron 3 insertion allele, TP53 intron 6 A allele, TP53 Pro72 (C) allele, and p21 codon 31 A allele were consistently enriched among exposed individuals. The strongest deviations were observed in Russian workers from Stepnogorsk (p < 0.01). These alleles are functionally associated with enhanced DNA repair efficiency, modified apoptotic responses, and strengthened cell-cycle checkpoint regulation. Conclusions: Significant enrichment of radioresistance-associated TP53 and CDKN1A (p21) variants was observed in uranium industry workers chronically exposed to low-to-moderate ionizing radiation. The observed patterns support a polygenic model of adaptive responses and emphasize the importance of genetic background in determining individual radiosensitivity under occupational exposure conditions.

## Linked entities

- **Genes:** TP53 (tumor protein p53) [NCBI Gene 7157], CDKN1A (cyclin dependent kinase inhibitor 1A) [NCBI Gene 1026], APC (APC regulator of Wnt signaling pathway) [NCBI Gene 324], VEGFA (vascular endothelial growth factor A) [NCBI Gene 7422], ERCC2 (ERCC excision repair 2, TFIIH core complex helicase subunit) [NCBI Gene 2068], RAD51 (RAD51 recombinase) [NCBI Gene 5888]
- **Proteins:** CDKN1A (cyclin dependent kinase inhibitor 1A)

## Full-text entities

- **Genes:** APC (APC regulator of Wnt signaling pathway) [NCBI Gene 324] {aka BTPS2, DESMD, DP2, DP2.5, DP3, GS}, RAD51 (RAD51 recombinase) [NCBI Gene 5888] {aka BRCC5, FANCR, HRAD51, HsRad51, HsT16930, MRMV2}, ATM (ATM serine/threonine kinase) [NCBI Gene 472] {aka AT1, ATA, ATC, ATD, ATDC, ATE}, ERCC2 (ERCC excision repair 2, TFIIH core complex helicase subunit) [NCBI Gene 2068] {aka COFS2, CXPD, EM9, TFIIH, TTD, TTD1}, CDKN1A (cyclin dependent kinase inhibitor 1A) [NCBI Gene 1026] {aka CAP20, CDKN1, CIP1, MDA-6, P21, SDI1}, TP53 (tumor protein p53) [NCBI Gene 7157] {aka BCC7, BMFS5, LFS1, P53, TRP53}, VEGFA (vascular endothelial growth factor A) [NCBI Gene 7422] {aka L-VEGF, MVCD1, VEGF, VPF}
- **Diseases:** cardiovascular diseases (MESH:D002318), gastrointestinal injury (MESH:D005767), ARS (MESH:D054508), cancer (MESH:D009369), injury to (MESH:D014947), hereditary disorders (MESH:D009386), metabolic dysregulation (MESH:D021081), hematopoietic suppression (MESH:D019337), multi-organ failure (MESH:D009102), carcinogenesis (MESH:D063646), immune-mediated disorders (MESH:C567355)
- **Chemicals:** Chernobyl (-), AL (MESH:D000535), silica (MESH:D012822), radon (MESH:D011886), thorium (MESH:D013910), uranium (MESH:D014501), potassium-40 (MESH:C000615339), agarose (MESH:D012685), ethidium bromide (MESH:D004996), EDTA (MESH:D004492), uranium-238 (MESH:C000615179), polyacrylamide (MESH:C016679), thorium-232 (MESH:C000615164), ethanol (MESH:D000431)
- **Species:** Homo sapiens (human, species) [taxon 9606]
- **Mutations:** rs1801320, Arg/Pro, Pro/Pro, rs13181, rs1801270, Ser/Ser, Arg72Pro, Arg/Arg, Ser/Arg, G>A, rs17878362

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12940297/full.md

---
Source: https://tomesphere.com/paper/PMC12940297